Argos Therapeutics Inc (NASDAQ:ARGS)

During the Trading Day
6.66 -0.02 / -0.30%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.19 -0.47 / -7.06%
 
Volume: 700.00
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close6.68
Today’s open6.65
Day’s range6.50 - 6.70
Volume23,465
Average volume (3 months)25,305
Market cap$138.2M
Dividend yield--
Data as of 3:59pm ET, 07/06/2015

Growth & Valuation

Earnings growth (last year)+87.30%
Earnings growth (this year)+0.27%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.36%
P/E ratioNM
Price/Sales87.98
Price/Book4.19

Competitors

 Today’s
change
Today’s
% change
NERVMinerva Neuroscience...-0.01-0.18%
XENEXenon Pharmaceutical...+0.02+0.20%
GLYCGlycoMimetics Inc-0.08-1.08%
BLRXBioLine RX Ltd-0.08-3.20%
Data as of 4:00pm ET, 07/06/2015

Financials

Next reporting dateAugust 13, 2015
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$2.0M
Annual profit (last year)-$53.3M
Net profit margin-2,700.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers